The companies we back are changing the ways people live and work

Our companies

A new class of drugs to regulate the human microbiome

Revolutionising cancer therapy with transport oncophysics

Joint pain relief through lipid formulated ibuprofen

Known drugs, made better

A clear vision for the treatment of ophthalmic disease

Leading the world in tumour re-engineering

Fighting cancers with engineered NKT cells

Hambro Perks Limited and members of the Hambro Perks group of companies (together, the “HP Group”) include Hambro Perks Asset Management Limited (“HPAM Ltd”) and Hambro Perks Advisory LLP (“HPA LLP”).

HPAM Ltd is a non-cellular company incorporated in Guernsey with company number 64127 and registered office at PO Box 286, 2nd Floor, Trafalgar Court, Les Banques, St Peter Port, Guernsey, GY1 4LY. HPAM Ltd is licensed under the Protection of Investors (Bailiwick of Guernsey) Law, 1987, by the Guernsey Financial Services Commission with reference number 2293289.

HPA LLP is a Limited Liability Partnership registered in England with company number OC419104, with registered office at 111 Buckingham Palace Road, London SW1W 0SR. HPA LLP is an appointed representative of Alternative St James LLP which is authorised and regulated by the Financial Conduct Authority with FCA number 430914. HPA LLP’s FCA number is 791891.